Attached files
| file | filename |
|---|---|
| S-1/A - S-1/A - Syneos Health, Inc. | a2221833zs-1a.htm |
| EX-5.1 - EX-5.1 - Syneos Health, Inc. | a2221833zex-5_1.htm |
| EX-4.1 - EX-4.1 - Syneos Health, Inc. | a2221833zex-4_1.htm |
| EX-10.16 - EX-10.16 - Syneos Health, Inc. | a2221833zex-10_16.htm |
| EX-1.1 - EX-1.1 - Syneos Health, Inc. | a2221833zex-1_1.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated July 17, 2014, (except Note 1 and Note 17, as to which the date is , 2014), in Amendment No. 2 to the Registration Statement (Form S-1 No. 333-199178) and related Prospectus of INC Research Holdings, Inc. for the registration of 8,108,108 shares of its common stock.
Ernst & Young LLP
Raleigh, North Carolina
The foregoing consent is in the form that will be signed upon the completion of the reverse stock split described in Note 1 and Note 17 to the financial statements.
/s/ Ernst & Young LLP
Raleigh, North Carolina
October 24, 2014